Professional Documents
Culture Documents
Topic 4 Handout
Copyright
Copyright© Egerton University
Published 2020
All rights reserved. No part of this publication may be reproduced, stored in a
retrieval system or transmitted in any form or by any means, electronic, mechanical,
photocopying, recording, or otherwise, without the prior written permission of the
copyright owner.
Introduction
In our first topic, we learned that HIV infection can cause immunodeficiency
disease called HIV/AIDS. In this topic we discuss the nature of HIV particle in
terms of its structure, characteristics, genetics, classification as well as its origin
and distribution.
Learning Outcomes
Viruses are simple acellular entities consisting of one or more of either DNA or
RNA enclosed in a shell of protein. Viruses are very small, sizes range 20 - 200
nm, beyond the resolving power of the light microscope. Viruses are
metabolically inert and can only replicate inside a host cell. Infectious virus
particle is called virion. Protein shell which surrounds and protects the genome is
called capsid. It is built up of multiple (identical) protein sub-units called
capsomers. Capsids are either icosahedral or tubular in shape. The genome
together witht the capsid is called Nucleocapsid.
b) Classification of Viruses
HIV particles surround themselves with a coat of fatty material known as the viral
envelope (or membrane) (Figure 4.2). Projecting from its surface are about 72
little spikes, which are formed from the glycoprotein 120 (gp120) and gp41. Just
below the viral envelope is a layer called the matrix, which is made from the
protein p17. The viral core (or capsid) is usually bullet-shaped and is made from
the protein p24. Inside the core are three enzymes required for HIV replication
HIV genome has nine genes (compared to more than 500 genes in a bacterium).
These genes are grouped as either structural genes or regulatory genes (Figure
4.3). Structural genes contain information needed to make structural proteins for
new virus particles while regulatory genes code for proteins that control the ability
of HIV to infect a cell, produce new copies of virus, or cause disease. At either
end of the ssRNA is a long terminal repeat sequence (LTR), which helps to
control HIV replication.
i) Structural genes
Figure 4.3: The HIV genome (Adapted from: Hoffmann and Rockstroh, 2012;
Battacharya and Sinha, 2006)
HIV is a highly variable virus which mutates very readily; hence there are many
different strains of HIV, even within the body of a single infected person. Based
on genetic similarities, the numerous virus strains may be classified into types,
groups and subtypes. There are two types of HIV: HIV-1 and HIV-2. Each HIV
type is divided into groups, and each group is divided into subtypes and CRFs
(Figure 4.3). The strains of HIV-1 can be classified into four groups on the basis
of differences in env gene and their SIV origin:
a) Origin of HIV
HIV particle was first widely recognized in 1981, although evidence of the virus
was found in stored blood collected in 1959, and so it seems that it has been in
existence for longer than was first thought. Both HIV-1 and HIV-2 are believed
to have originated in West-Central Africa and jumped species (zoonosis) from a
non-human primate to humans in the twentieth century.
i) HIV-2
ii) HIV-1
Worldwide, the predominant virus is HIV-1, and generally when people refer to
HIV without specifying the type of virus, they will be referring to HIV-1. HIV-1
is more pathogenic than HIV-2. The reason seems simply that once it's integrated
into a cell, it is faster at producing new virus particles. Group O appears to be
restricted to west-Central Africa while group N and Pare extremely rare. Group M
is most prevalent and is responsible for more than 90% of HIV-1 infections.
Within group M the most prevalent are subtypes B (found mainly in North
America and Europe), A and D (found mainly in Africa), and C (found mainly in
Africa and Asia). Subtype E is found in Thailand, Japan and India. Occasionally,
two viruses of different subtypes can meet in the cell of an infected person and
form a hybrid known as "circulating recombinant forms" or CRFs. For
example, the CRF A/B is a mixture of subtypes A and B.
Topic Summary